title: AT2 receptor activities and pathophysiological implications.
abstract: Although angiotensin II subtype-2 receptor (AT2R) was discovered over 2 decades ago, its contribution to physiology and pathophysiology is not fully elucidated. Current knowledge suggests that under normal physiologic conditions, AT2R counterbalances the effects of angiotensin II subtype-1 receptor (AT1R). A major obstacle for AT2R investigations was the lack of specific agonists. Most of the earlier AT2R studies were performed using the peptidic agonist, CG42112A, or the nonpeptidic antagonist PD123319. CGP42112A is nonspecific for AT2R and in higher concentrations can bind to AT1R. Recently, the development of specific nonpeptidic AT2R agonists boosted the efforts in identifying the therapeutic potentials for AT2R stimulation. Unlike AT1R, AT2R is involved in vasodilation by the release of bradykinin and nitric oxide, anti-inflammation, and healing from injury. Interestingly, the vasodilatory effects of AT2R stimulation were not associated with significant reduction in blood pressure. In the kidney, AT2R stimulation produced natriuresis, increased renal blood flow, and reduced tissue inflammation. In animal studies, enhanced AT2R function led to reduction of cardiac inflammation and fibrosis, and reduced the size of the infarcted area. Similarly, AT2R stimulation demonstrated protective effects in vasculature and brain.
authors: Department of Medicine, University of Virginia Health System, Charlottesville, VA.
authors: Luis C
authors: LC
authors: Matavelli
authors: Helmy M
authors: HM
authors: Siragy
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D002317:Cardiovascular Agents / Q000494:pharmacology; D002319:Cardiovascular System / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D015195:Drug Design; D005355:Fibrosis; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D058990:Molecular Targeted Therapy; D018696:Neuroprotective Agents / Q000494:pharmacology; D044139:Receptor, Angiotensin, Type 2 / Q000819:agonists* / Q000378:metabolism; D012084:Renin-Angiotensin System / Q000187:drug effects*; D015398:Signal Transduction / Q000187:drug effects; D020257:Ventricular Remodeling / Q000187:drug effects
chemical_list: D000893:Anti-Inflammatory Agents; D002317:Cardiovascular Agents; D018696:Neuroprotective Agents; D044139:Receptor, Angiotensin, Type 2
references: Cardiovasc Res. 2004 Jun 1;62(3):587-93
references: 15158151
references: Br J Pharmacol. 2010 Feb 1;159(3):709-16
references: 20128808
references: Biochem Biophys Res Commun. 1994 Sep 30;203(3):1842-50
references: 7945336
references: J Hypertens. 2009 Dec;27(12):2444-51
references: 19680135
references: Hypertension. 2011 Feb;57(2):275-82
references: 21189402
references: Am J Hypertens. 2005 Apr;18(4 Pt 1):493-9
references: 15831358
references: Biochem Biophys Res Commun. 1991 Dec 31;181(3):1365-71
references: 1764088
references: Proc Natl Acad Sci U S A. 1999 May 25;96(11):6506-10
references: 10339618
references: Circ Res. 1995 Dec;77(6):1070-6
references: 7586218
references: Cardiovasc Diagn Ther. 2012 Mar;2(1):56-62
references: 24282697
references: Hypertension. 2006 Mar;47(3):537-44
references: 16380540
references: J Biol Chem. 1996 Sep 6;271(36):21985-92
references: 8703004
references: J Clin Invest. 1996 Apr 15;97(8):1978-82
references: 8621783
references: Int J Cardiol. 2013 Nov 15;169(4):281-7
references: 24161533
references: Hypertension. 2007 Jul;50(1):96-102
references: 17485601
references: J Med Chem. 2004 Nov 18;47(24):5995-6008
references: 15537354
references: Am J Physiol Lung Cell Mol Physiol. 2013 Sep;305(5):L341-51
references: 23812633
references: Circulation. 2004 Aug 17;110(7):843-8
references: 15289370
references: Hypertension. 2003 Oct;42(4):500-6
references: 12925562
references: Hypertension. 2011 Feb;57(2):308-13
references: 21189405
references: Endocr J. 1998 Apr;45(2):137-50
references: 9700467
references: Endocrinology. 2011 Apr;152(4):1582-8
references: 21303953
references: Stroke. 2009 Apr;40(4):1482-9
references: 19246705
references: Hypertension. 2009 Feb;53(2):256-61
references: 19114640
references: Clin Sci (Lond). 2011 Oct;121(7):297-303
references: 21542804
references: Hypertension. 2005 May;45(5):840-4
references: 15738342
references: Am J Hypertens. 2014 Aug;27(8):1036-44
references: 24572705
references: Hypertension. 1996 Mar;27(3 Pt 2):529-34
references: 8613198
references: Nat Genet. 2005 Sep;37(9):964-8
references: 16116425
references: Hypertension. 1999 May;33(5):1237-42
references: 10334818
references: Hypertension. 2011 Mar;57(3):570-6
references: 21300665
references: J Med Chem. 1993 Dec 10;36(25):3985-92
references: 8258820
references: Kidney Int Suppl. 1997 Dec;63:S205-7
references: 9407460
references: Hypertension. 2006 Aug;48(2):316-22
references: 16754789
references: J Cereb Blood Flow Metab. 2012 Feb;32(2):248-55
references: 21971355
references: Neuropharmacology. 2014 Jun;81:134-41
references: 24508710
references: Hypertension. 2012 Feb;59(2):485-92
references: 22215717
references: Hypertension. 2003 Oct;42(4):600-4
references: 12953015
references: Hypertension. 2005 Dec;46(6):1261-2
references: 16286568
references: Br J Pharmacol. 2001 Oct;134(4):865-70
references: 11606327
references: Semin Nephrol. 2004 Mar;24(2):93-100
references: 15017521
references: Am J Hypertens. 2011 Jun;24(6):724-30
references: 21394088
references: PLoS One. 2013;8(12):e82997
references: 24340072
references: Br J Pharmacol. 2002 Jun;136(4):484-91
references: 12055126
references: Am J Hypertens. 2014 Oct;27(10):1248-56
references: 24687998
references: J Med Chem. 2012 Mar 8;55(5):2265-78
references: 22248302
references: Am J Physiol. 1998 Sep;275(3 Pt 2):H906-16
references: 9724295
references: Circulation. 2004 May 18;109(19):2296-301
references: 15117835
references: J Clin Invest. 1997 Jul 15;100(2):264-9
references: 9218502
references: J Clin Invest. 1998 Feb 15;101(4):755-60
references: 9466969
references: Am J Physiol Renal Physiol. 2010 Mar;298(3):F807-17
references: 20032120
references: Hypertension. 1999 Nov;34(5):1112-6
references: 10567191
references: J Med Chem. 1991 Nov;34(11):3248-60
references: 1956044
references: Hypertension. 2001 May;37(5):1199-208
references: 11358929
references: Am J Hypertens. 2005 Sep;18(9 Pt 2):134S-141S
references: 16125050
references: J Biol Chem. 1993 Nov 25;268(33):24543-6
references: 8227011
references: Hypertension. 2001 Dec 1;38(6):1272-7
references: 11751702
references: Am J Physiol. 1999 Sep;277(3 Pt 2):F437-46
references: 10484527
references: Hypertension. 2007 Feb;49(2):341-6
references: 17159079
references: Biochem Biophys Res Commun. 1989 Aug 30;163(1):284-91
references: 2775266
references: Circulation. 2005 Nov 22;112(21):3328-36
references: 16286588
references: Integr Blood Press Control. 2013 Nov 22;6:153-61
references: 24379697
references: Hypertension. 2013 Nov;62(5):920-6
references: 24041944
references: Hypertension. 1997 Nov;30(5):1238-46
references: 9369282
references: J Pharmacol Exp Ther. 2004 Feb;308(2):736-43
references: 14610239
references: Nature. 1995 Oct 26;377(6551):748-50
references: 7477267
references: Mol Cell. 1999 Jan;3(1):1-10
references: 10024874
references: Kidney Int. 2013 Nov;84(5):931-9
references: 23823602
references: Circulation. 2008 Dec 9;118(24):2523-32
references: 19029468
references: PLoS One. 2014;9(4):e95762
references: 24752645
references: J Biol Chem. 1993 Nov 25;268(33):24539-42
references: 8227010
references: J Cardiovasc Pharmacol. 2012 Apr;59(4):363-8
references: 22157261
references: FASEB J. 2005 Apr;19(6):617-9
references: 15665034
references: Kidney Int. 2000 Jan;57(1):191-202
references: 10620200
references: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15496-501
references: 9860997
references: Kidney Int Suppl. 2003 Oct;(86):S21-6
references: 12969123
references: Hypertension. 2012 Sep;60(3):722-9
references: 22802221
references: Eur J Biochem. 1996 Aug 1;239(3):558-65
references: 8774697
references: Curr Hypertens Rep. 2012 Oct;14(5):403-9
references: 22836386
references: Hypertension. 2002 Oct;40(4):516-20
references: 12364356
references: Nature. 1995 Oct 26;377(6551):744-7
references: 7477266
references: Hypertension. 2012 Feb;59(2):409-14
references: 22158645
references: Br J Pharmacol. 2000 Jun;130(3):521-6
references: 10821779
references: J Med Chem. 2005 Jun 16;48(12):4009-24
references: 15943474
references: Hypertension. 2012 Feb;59(2):291-9
references: 22184324
references: Hypertension. 2010 Apr;55(4):924-31
references: 20157051
references: J Vasc Res. 1998 Nov-Dec;35(6):421-7
references: 9858867
references: Hypertension. 2014 Aug;64(2):378-83
references: 24842923
references: J Renin Angiotensin Aldosterone Syst. 2010 Dec;11(4):214-21
references: 20807798
references: J Biol Chem. 1996 Jun 21;271(25):15026-33
references: 8663053
references: Hypertension. 2008 Oct;52(4):708-14
references: 18768398